|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2008-06-10 Purchase |
2008-06-10 7:37 pm | ARENA PHARMACEUTICALS INC | ARNA | HIXSON HARRY F JR (Director) | 20,000 | $4.687 | $93,740 | 30,000 (Direct) | View |
| 2005-09-21 Purchase |
2005-09-21 3:12 pm | ARENA PHARMACEUTICALS INC | ARNA | HIXSON HARRY F JR (Director) | 10,000 | $8.96 | $89,600 | 10,000 (Direct) |
View |
| Transaction & Date | Reported Date |
Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded |
Conversion Price | Shares Ownership |
Filing |
| 2008-05-30 Option Award | 2008-06-02 6:38 pm |
N/A 2018-05-30 | SEQUENOM INC | SQNM | HIXSON HARRY F JR (Director) | 20,000 | $7.69 | 20,000 (Direct) | View |
| 2008-03-03 Option Award | 2008-03-05 6:42 pm | N/A 2018-03-03 | ARENA PHARMACEUTICALS INC | ARNA | HIXSON HARRY F JR (Director) | 20,584 | $6.99 | 20,584 (Direct) |
View |
| 2007-06-22 Option Award |
2007-06-25 3:05 pm | N/A 2017-06-22 |
SEQUENOM INC | SQNM | HIXSON HARRY F JR (Director) | 20,000 | $4.58 | 20,000 (Direct) | View |
| 2007-02-26 Option Award | 2007-02-27 8:35 pm |
N/A 2017-02-26 | ARENA PHARMACEUTICALS INC | ARNA | HIXSON HARRY F JR (Director) | 16,444 | $13.5 | 16,444 (Direct) | View |
| 2006-09-12 Option Award | 2006-09-13 7:59 pm | N/A 2016-09-12 | INFINITY PHARMACEUTICALS, INC. | INFI | HIXSON HARRY F JR (Director) | 28,125 | $15.04 | 28,125 (Direct) | View |
| 2006-07-28 Option Award | 2006-08-01 7:48 pm | N/A 2016-07-28 |
ARENA PHARMACEUTICALS INC | ARNA | HIXSON HARRY F JR (Director) | 15,703 | $10.52 | 15,703 (Direct) |
View |
| 2006-06-06 Option Award | 2006-06-08 5:45 pm | N/A 2016-06-05 | SEQUENOM INC | SQNM* | HIXSON HARRY F JR (Director) | 50,000 | $1.87 | 50,000 (Direct) |
View |
| 2006-05-11 Option Award | 2006-05-12 2:14 pm | 2007-05-11 2016-05-11 |
DISCOVERY PARTNERS INTERNATIONAL INC | DPII | HIXSON HARRY F JR (Director) | 25,000 | $2.5 | 25,000 (Direct) |
View |
| 2005-06-17 Option Award |
2005-06-20 4:02 pm | 2006-06-17 2015-06-17 |
SEQUENOM INC | SQNM | HIXSON HARRY F JR (Director) | 15,000 | $1.16 | 15,000 (Direct) |
View |
| 2005-05-12 Option Award |
2005-05-13 1:43 pm |
2006-05-12 2015-05-12 |
DISCOVERY PARTNERS INTERNATIONAL INC | DPII | HIXSON HARRY F JR (Director) | 15,000 | $3.03 | 15,000 (Direct) |
View |
| 2005-01-17 Option Award |
2005-01-18 8:22 pm |
2005-01-17 2015-01-17 | ARENA PHARMACEUTICALS INC | ARNA | HIXSON HARRY F JR (Director) | 10,000 | $6.16 | 10,000 (Direct) |
View |
| 2005-01-17 Option Award | 2005-01-18 8:22 pm | 2005-01-17 2015-01-17 | ARENA PHARMACEUTICALS INC | ARNA | HIXSON HARRY F JR (Director) | 9,740 | $6.16 | 9,740 (Direct) |
View |
| 2004-09-14 Option Award |
2004-09-15 10:37 am | 2004-09-14 2014-09-14 |
ARENA PHARMACEUTICALS INC | ARNA | HIXSON HARRY F JR (Director) | 25,000 | $4.11 | 25,000 (Direct) | View |
| 2004-09-14 Option Award |
2004-09-15 10:37 am | 2004-09-14 2014-09-14 |
ARENA PHARMACEUTICALS INC | ARNA | HIXSON HARRY F JR (Director) | 14,599 | $4.11 | 14,599 (Direct) | View |
| 2004-05-14 Option Award | 2004-05-18 6:12 pm |
2005-05-14 2014-05-14 |
SEQUENOM INC | SQNM | HIXSON HARRY F JR (Director) | 15,000 | $1.74 | 15,000 (Direct) | View |
| 2004-05-13 Option Award |
2004-05-17 8:35 pm | 2005-05-13 2014-05-13 |
DISCOVERY PARTNERS INTERNATIONAL INC | DPII | HIXSON HARRY F JR (Director) | 15,000 | $5.2 | 15,000 (Direct) |
View |
|
© 2005-2008 SecForm4.Com All rights reserved. Archives: 2008 2007 2006 2005 2004 2003 Sun, 23 Nov 2008 05:24:42 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |